Search research articles
Contact Us
Filters
Showing results (531-540 of 540) with videos related to
Page
of 54
Sort By:
You have reached the last page of results.
This site can display upto 540 results.
Journal of Medicinal Chemistry
|
February 17, 2006
Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors
Sylvester R Klutchko, Hairong Zhou, R Thomas Winters, et al.
JCI Insight
|
October 22, 2024
Distinct strategies for intravascular triglyceride metabolism in hearts of mammals and lower vertebrate species
Le Phuong Nguyen, Wenxin Song, Ye Yang, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2015
Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability
Martin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Plos One
|
February 11, 2026
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
Hannah R Volkman, Leonie de Munter, Jennifer L Nguyen, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 15, 2022
Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
Gerard J Criner, Frederick M Lang, Robert L Gottlieb, et al.
RSC Medicinal Chemistry
|
March 22, 2024
Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex
Aliakbar Khalili Yazdi, Sumera Perveen, Cheng Dong, et al.
Journal of Medicinal Chemistry
|
June 7, 2024
Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease
Martin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Frontiers in Immunology
|
May 21, 2021
Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD
Mayela Mendt, May Daher, Rafet Basar, et al.
La Clinica Terapeutica
|
October 14, 2024
Vietnam Association of Gastroenterology consensus for the diagnosis and treatment of functional dyspepsia
K-T T Tran, B H Mai, L Ta, et al.
The Lancet Regional Health. Western Pacific
|
May 23, 2022
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
Thuy P Nguyen, Quyet Do, Lan T Phan, et al.
Page
of 54
Search research articles
Search
Showing results (531-540 of 540) with videos related to
Sort By:
Page
of 54
You have reached the last page of results.
This site can display upto 540 results.
Journal of Medicinal Chemistry
|
February 17, 2006
Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors
Sylvester R Klutchko, Hairong Zhou, R Thomas Winters, et al.
JCI Insight
|
October 22, 2024
Distinct strategies for intravascular triglyceride metabolism in hearts of mammals and lower vertebrate species
Le Phuong Nguyen, Wenxin Song, Ye Yang, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2015
Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability
Martin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Plos One
|
February 11, 2026
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
Hannah R Volkman, Leonie de Munter, Jennifer L Nguyen, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 15, 2022
Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
Gerard J Criner, Frederick M Lang, Robert L Gottlieb, et al.
RSC Medicinal Chemistry
|
March 22, 2024
Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex
Aliakbar Khalili Yazdi, Sumera Perveen, Cheng Dong, et al.
Journal of Medicinal Chemistry
|
June 7, 2024
Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer's Disease
Martin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Frontiers in Immunology
|
May 21, 2021
Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD
Mayela Mendt, May Daher, Rafet Basar, et al.
La Clinica Terapeutica
|
October 14, 2024
Vietnam Association of Gastroenterology consensus for the diagnosis and treatment of functional dyspepsia
K-T T Tran, B H Mai, L Ta, et al.
The Lancet Regional Health. Western Pacific
|
May 23, 2022
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
Thuy P Nguyen, Quyet Do, Lan T Phan, et al.
Page
of 54